Q1 2022 Holdings
Filed 2022-05-16 | 118 holdings | $24.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Colombier Acquisition Corp | *W EXP 99/99/999 | 19533H116 | $5 | 16,666 | 0.0% |
| Coliseum Acquisition Corp | *W EXP 08/22/202 | G2263T107 | $10 | 28,333 | 0.0% |
| Giginternational1 Inc | *W EXP 04/19/202 | 37518W114 | $18 | 50,000 | 0.0% |
| Industrial Human Capital Inc | *W EXP 11/27/202 | 45617P112 | $18 | 100,000 | 0.0% |
| Ault Disruptive Techs Corp | *W EXP 99/99/999 | 05150A112 | $19 | 112,500 | 0.0% |
| OPY Acquisition Corp I | *W EXP 09/22/202 | 671005114 | $20 | 50,000 | 0.0% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $21 | 82,233 | 0.0% |
| Turmeric Acquisition Corp | *W EXP 10/08/202 | G9127T124 | $24 | 84,666 | 0.0% |
| Eucrates Biomedical Acqu COR | *W EXP 10/23/202 | G3141W122 | $25 | 133,333 | 0.0% |
| Sarissa Capital Acquisitn Co | *W EXP 10/23/202 | G7823W110 | $27 | 75,000 | 0.0% |
| Chavant Capital Acquisitn Co | *W EXP 99/99/999 | G2058L111 | $30 | 150,000 | 0.0% |
| Lakeshore Acquisition I Corp | *W EXP 07/15/202 | G53521111 | $53 | 150,000 | 0.0% |
| NLS Pharmaceutics LTD | *W EXP 09/25/202 | H57830111 | $76 | 200,000 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $82 | 202,276 | 0.0% |
| Nexgel Inc | *W EXP 12/01/202 | 65344E115 | $88 | 225,000 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $99 | 10,000 | 0.0% |
| Nocturne Acquisition Corp | RIGHT 12/26/2025 | G6580S106 | $105 | 500,000 | 0.0% |
| Cingulate Inc(CINGW) | *W EXP 12/03/202 | 17248W113 | $108 | 270,000 | 0.0% |
| Direct Digital Holdings Inc | *W EXP 02/15/202 | 25461T113 | $131 | 180,000 | 0.0% |
| Pepperlime Health Acqustn Co | *W EXP 10/01/202 | G70021111 | $152 | 367,500 | 0.0% |
| Immatics N.v | *W EXP 07/01/202 | N44445117 | $171 | 97,467 | 0.0% |
| CEA Industries Inc(BNCWW) | *W EXP 02/11/202 | 86887P119 | $171 | 250,000 | 0.0% |
| Harbor Custom Development in | *W EXP 05/09/202 | 41150T116 | $171 | 600,000 | 0.0% |
| Surgepays Inc | *W EXP 10/22/202 | 86882L113 | $223 | 250,000 | 0.0% |
| Harbor Custom Development in | *W EXP 10/04/202 | 41150T124 | $240 | 650,000 | 0.0% |
| Renovacor Inc | *W EXP 99/99/999 | 75989E114 | $249 | 731,561 | 0.0% |
| Lightning Emotors Inc | *W EXP 05/18/202 | 53228T119 | $268 | 652,173 | 0.0% |
| TC Biopharm Holdings PLC | *W EXP 02/08/202 | 87807D111 | $461 | 941,176 | 0.0% |
| Colombier Acquisition Corp | CL A | 19533H108 | $484 | 50,000 | 0.0% |
| GSR II Meteora Acquisitn COR | UNIT 02/24/2027 | 36263W204 | $506 | 50,000 | 0.0% |
| Doubledown Interactive Co LT(DDI) | ADS | 25862B109 | $722 | 60,876 | 0.0% |
| Verrica Pharmaceuticals Inc | COM | 92511W108 | $794 | 97,887 | 0.0% |
| VIQ Solutions Inc(VQSSF) | COM NEW | 91825V400 | $798 | 489,417 | 0.0% |
| Coliseum Acquisition Corp | CLASS A ORD SHS | G2263T123 | $825 | 85,000 | 0.0% |
| Muscle Maker Inc | COM | 627333107 | $948 | 1,796,961 | 0.0% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $980 | 100,000 | 0.0% |
| OPY Acquisition Corp I | COM CL A | 671005106 | $980 | 100,000 | 0.0% |
| Omega Alpha Spac | CL A | G6749V107 | $982 | 100,000 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $987 | 100,000 | 0.0% |
| Western Acqstn Ventures Corp | UNIT 09/01/2026 | 95758L206 | $1.0K | 100,000 | 0.0% |
| Industrial Human Capital Inc | COM | 45617P104 | $1.0K | 100,000 | 0.0% |
| Relativity Acquisition Corp | UNIT 02/10/2027 | 75944B205 | $1.0K | 100,000 | 0.0% |
| Murphy Canyon Acquisition Co | UNIT 01/25/2027 | 626642201 | $1.0K | 100,000 | 0.0% |
| FAT Brands Inc | *W EXP 07/16/202 | 30258N121 | $1.0K | 227,000 | 0.0% |
| Cutera Inc(CUTREUR) | COM | 232109108 | $1.0K | 15,000 | 0.0% |
| Profound MED Corp(PROF) | COM NEW | 74319B502 | $1.1K | 124,945 | 0.0% |
| Tailwind Acquisition Corp | COM CL A | 87403Q102 | $1.3K | 128,414 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $1.3K | 540,800 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $1.4K | 22,500 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $1.4K | 299,800 | 0.0% |